NCT05873686 2026-03-03A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersNuvectis Pharma, Inc.Phase 1 Recruiting140 enrolled
NCT05795595 2025-11-26A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsCRISPR TherapeuticsPhase 1/2 Completed19 enrolled
NCT03618381 2025-11-20EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's HospitalPhase 1 Active not recruiting44 enrolled
NCT04483778 2025-11-20B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's HospitalPhase 1 Active not recruiting68 enrolled